Dyadic International Inc (DYAI)
1.65
+0.04
(+2.24%)
USD |
NASDAQ |
May 21, 13:22
Dyadic International Free Cash Flow (Quarterly): -1.113M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.113M |
December 31, 2023 | -0.9234M |
September 30, 2023 | -1.962M |
June 30, 2023 | -1.655M |
March 31, 2023 | -2.187M |
December 31, 2022 | -1.682M |
September 30, 2022 | -1.776M |
June 30, 2022 | -1.775M |
March 31, 2022 | -2.850M |
December 31, 2021 | -2.635M |
September 30, 2021 | -4.334M |
June 30, 2021 | -2.401M |
March 31, 2021 | -1.906M |
December 31, 2020 | -1.287M |
September 30, 2020 | -1.384M |
June 30, 2020 | -1.908M |
March 31, 2020 | -1.996M |
December 31, 2019 | -1.401M |
September 30, 2019 | -1.541M |
June 30, 2019 | -1.431M |
March 31, 2019 | -1.410M |
December 31, 2018 | -1.229M |
September 30, 2018 | -0.8013M |
June 30, 2018 | -1.716M |
March 31, 2018 | -0.6608M |
Date | Value |
---|---|
December 31, 2017 | -1.160M |
September 30, 2017 | -1.694M |
June 30, 2017 | 1.913M |
March 31, 2017 | -0.7498M |
December 31, 2016 | -1.496M |
September 30, 2016 | -4.316M |
June 30, 2016 | 1.925M |
March 31, 2016 | -2.144M |
December 31, 2015 | -2.717M |
September 30, 2015 | 1.377M |
June 30, 2015 | 1.441M |
March 31, 2015 | -0.9045M |
December 31, 2014 | |
September 30, 2014 | |
March 31, 2014 | -1.926M |
December 31, 2013 | 0.3966M |
September 30, 2013 | 1.361M |
June 30, 2013 | 2.874M |
March 31, 2013 | 0.0576M |
September 30, 2012 | 0.6127M |
June 30, 2012 | -0.9945M |
March 31, 2012 | -0.4776M |
December 31, 2006 | 8.834M |
September 30, 2006 | -0.9443M |
June 30, 2006 | -4.573M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-4.334M
Minimum
Sep 2021
-0.9234M
Maximum
Dec 2023
-1.907M
Average
-1.776M
Median
Free Cash Flow (Quarterly) Benchmarks
AIM ImmunoTech Inc | -4.865M |
Perspective Therapeutics Inc | 4.776M |
Protalix BioTherapeutics Inc | 3.59M |
Electromed Inc | 1.222M |
Armata Pharmaceuticals Inc | -10.83M |